What is Star Lake Bioscience Co Price-to-Operating-Cash-Flow?
As of today (2024-04-27), Star Lake Bioscience Co's share price is ¥5.04.
Star Lake Bioscience Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.51. Hence, Star Lake Bioscience Co's Price-to-Operating-Cash-Flow Ratio for today is 3.33.
The historical rank and industry rank for Star Lake Bioscience Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SHSE:600866'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.76 Med: 22.39 Max: 1646
Current: 3.31
During the past 13 years, Star Lake Bioscience Co's highest Price-to-Operating-Cash-Flow Ratio was 1646.00. The lowest was 2.76. And the median was 22.39.
Star Lake Bioscience Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥-0.12.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.51.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Star Lake Bioscience Co was 59.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 53.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 65.70% per year.
During the past 13 years, Star Lake Bioscience Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 175.90% per year. The lowest was -36.40% per year. And the median was 44.00% per year.
Star Lake Bioscience Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Star Lake Bioscience Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Lake Bioscience Co Price-to-Operating-Cash-Flow Chart
|
Star Lake Bioscience Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
15.58 |
14.76 |
29.86 |
4.24 |
3.82 |
|
Star Lake Bioscience Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
6.41 |
4.02 |
6.03 |
3.82 |
2.86 |
Competitive Comparison of Star Lake Bioscience Co's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Star Lake Bioscience Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's Price-to-Operating-Cash-Flow falls into.
Star Lake Bioscience Co Price-to-Operating-Cash-Flow Calculation
Star Lake Bioscience Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 5.04 | / | 1.513 |
| = | 3.33 |
Star Lake Bioscience Co's Share Price of today is ¥5.04.
Star Lake Bioscience Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Star Lake Bioscience Co (SHSE:600866) Business Description
Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Star Lake Bioscience Co (SHSE:600866) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600866 has been successfully added to your